Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6.
| Autor: | Chung, Andrew W., Kozielski, Anthony J., Qian, Wei, Zhou, Jianying, Anselme, Ann C., Chan, Alfred A., Pan, Ping-Ying, Lee, Delphine J., Chang, Jenny C. |
|---|---|
| Zdroj: | NPJ Breast Cancer; 3/8/2022, Vol. 8 Issue 1, p1-10, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink